|
English
|
正體中文
|
简体中文
|
總筆數 :2853524
|
|
造訪人次 :
45209050
線上人數 :
888
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"cortes"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2024-12 |
A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases
|
Andre;F;Cortes;J;Curigliano;G;Modi;S;Li;W;Park;Y, H.;Chung;W, -p.;Kim;S, -b.;Yamashita;T;Pedrini;J, L.;Im;S, -a.;Tseng;L, -m.;Harbeck;N;Krop;I;Nakatani;S;Tecson;K;Ashfaque;S;Egorov;A;Hurvitz;S, A. |
| 國立成功大學 |
2024-09 |
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer
|
Iwata;Hiroji;Xu;Binghe;Kim;Sung-Bae;Chung;Wei-Pang;Park;Hee, Yeon;Kim;Hwan, Min;Tseng;Ling-Ming;Chung;Chi-Feng;Huang;Chiun-Sheng;Kim;Hyun, Jee;Chiu;Yan, Joanne Wing;Yamashita;Toshinari;Li;Wei;Egorov;Anton;Nishijima;Soichiro;Nakatani;Shunsuke;Nishiyama;Yuji;Sugihara;Masahiro;Cortes;Javier;Im;Seock-Ah |
| 國立成功大學 |
2024-05 |
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
|
Hurvitz;S, A.;Kim;S, -B.;Chung;W, -P.;Im;S, -A.;Park;Y, H.;Hegg;R;Kim;M, -H.;Tseng;L, -M.;Petry;V;Chung;C, -F.;Iwata;H;Hamilton;E;Curigliano;G;Xu;B;Egorov;A;Liu;Y;Cathcart;J;Bako;E;Tecson;K;Verma;S;Cortes;J |
| 國立成功大學 |
2017-09-12 |
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
|
Tsai;Hui-Jen;Jiang;Sheng, Shih;Hung;Wen-Chun;Borthakur;Gautam;Lin;Sheng-Fung;Pemmaraju;Naveen;Jabbour;Elias;Bomalaski;John, S.;Chen;Ya-Ping;Hsiao;Hui-Hua;Wang;Ming-Chung;Kuo;Ching-Yuan;Chang;Hung;Yeh;Su-Peng;Cortes;Jorge;Chen;Li-Tzong;Chen;Tsai-Yun |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
